β‐Blocker Use in Heart Failure Patients with Airways Disease

Yazar: Shaw, Steven M., Hasleton, Jonathan, Williams, Simon G.
Yayımlandı Clin Cardiol (2009)

CMR in Heart Failure

Yazar: Sado, Daniel M., Hasleton, Jonathan M., Herrey, Anna S., Moon, James C.
Baskı/Yayın Bilgisi 2011

Cardiac Computed Tomography to Identify and Guide Therapy of Intramural Hemorrhage in High-Risk Coronary Anatomy

Yazar: Jatti, Kumar, Maurovich-Horvat, Pal, Hasleton, Jonathan, Uddin, Muezz, Ruzsics, Balazs
Yayımlandı JACC Case Rep (2021)

Assessment of the interstitial volume in healthy volunteers. An equilibrium contrast CMR study

Yazar: Sado, Daniel, Maestrini, Viviana, Flett, Andrew, White, Steven K, Banypersad, Sanjay M, Hasleton, Jonathan, Sado, Graham, Moon, James
Baskı/Yayın Bilgisi 2012

Not all LGE is the same. Scar contrast volume of distribution is lower in HCM than in infarction

Yazar: Treibel, Thomas A, White, Steven K, Sado, Daniel, Hasleton, Jonathan, Flett, Andrew, Herrey, Anna S, Hausenloy, Derek J, Moon, James
Baskı/Yayın Bilgisi 2012

Primary percutaneous coronary intervention in nonagenarians: is it worthwhile?

Yazar: Meah, Mohammed M. N., Joseph, Tobin, Ding, Wern Yew, Shaw, Matthew, Hasleton, Jonathan, Palmer, Nick D., Velavan, Periaswamy, Aggarwal, Suneil K.
Yayımlandı BMC Cardiovasc Disord (2021)

The quantification and role of diffuse myocardial fibrosis in familial dilated cardiomyopathy - an equilibrium contrast cmr study

Yazar: Sado, Daniel M, Flett, Andrew S, Cook, Christopher M, Coats, Caroline J, Quarta, Giovanni, Hasleton, Jonathan M, Hausenloy, Derek J, Elliott, Perry M, Moon, James C
Baskı/Yayın Bilgisi 2011

Erythropoietin doubles the incidence of microvascular obstruction in primary PCI - a randomized controlled trial in acute MI using CMR primary endpoints

Yazar: Puranik Raj, Taylor Andrew M, Muthurangu Vivek, Moon James C, Boston-Griffiths Edney, Babu Girish, Hasleton Jonathan M, Ludman Andrew J, Yellon Derek M, Hausenloy Derek J
Baskı/Yayın Bilgisi 2010-01-01